Using Old FDA Approved Drugs
We live in the greatest country in the world. That’s why the United States is fast tracking ways to fight against the coronavirus. Late this week generic drug Hydroxychloroquine (brand name Plaquenel) and Azithromycin combined together were learned to be effective against the virus.
Boston Medical Center
Meanwhile, a story broke Thursday 3/19 in the Boston Herald by Rick Sobey — “Boston Medical Center infectious diseases specialist told the Boston Herald the hospital is administering the drug to anyone who is either confirmed or suspected of having the virus”.
In addition, Sobey reported on the hope of Hydroxychloroquine, an old malaria drug used to treat autoimmune diseases. “They say it appears to stem inflammation and may decrease the viruses ability to reproduce”.
Also, in a Forbes article the same day by contributor Mary Beth Pfeiffer, detailed a study in Marseilles, France done by Didier Raoult and his team. They offer encouraging results in a trial using hydroxychloroquine and also in combination with the antibiotic azithromycin.
The Marseilles Study by Raoult
A total of 36 patients-including 20 treated individuals and 16 infected controls-were enrolled.
Basically, the findings show, “At day three, the study reported, 50% of the treated group turned from positive to negative for the COVID virus”.
In addition, Pfeiffer reported in her story, “By day six 70% tested negative”.
Furthermore, “As intriguing of the 20 test patients, six were treated with both Plaquenil and the antibiotic azithromycin did even better, the team reported. Five of the six, or 83%, tested negative at day three. All six, 100% tested negative at day six.
Finally, “Meantime, the control patients largely stayed sick longer. On days three and six, just 6.3% and 12.5%, respectively, tested negative”.
International Journal of Antimicrobial Agents
Then Pfeiffer stated further, “In a short paper published this month in the International Journal of Antimicrobial Agents, before their Marseille trial results were announced, Roualt and two colleagues commented on the Chinese team’s findings that spurred their work.
For one, they wrote, the drug’s “negligible” cost could allow use as both a treatment and prophylaxis for people exposed to the virus. “If clinical data confirm the biological results.” they posited, “the novel coronavirus-associated disease will have become one of the simplest and cheapest to treat and prevent among infectious respiratory diseases”.
President Trump Tweet
Similarly this morning 3/21 President Trump tweeted, “Hydroxychloroquine & Azithromycin taken together, have a real chance to be one of the biggest game changers in the history of medicine. The FDA has moved mountains- Thank you! Hopefully they will BOTH (H works better with A, International Journal of Antimicrobial Agents)”.
University of Minnesota Study
Lastly, reported by Adam Rawnsley in Daily Beast Friday 3/20 is research being conducted at University of Minnesota. A large scale study “in human trials to see whether or not hydroxycholoroquine can prevent healthcare workers and others exposed to the virus from getting sick”. This would reduce fear, anxiety and uncertainty of those passionately serving the sick.
Ultimately, I believe these lead to a quantum turnaround in the pandemic the world faces. Affecting the livelihood of Americans and others across the globe.
Connect with me in how to create the life you want rather than default to the future in front of you Brenyammon@gmail.com